---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-029638"
form_type: "8-K"
ticker: "MRKR"
cik: "0001094038"
company_name: "Marker Therapeutics, Inc."
filed_at: "2024-03-01T23:59:59+00:00"
generated_at: "2026-06-05T05:16:57.482466+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Marker Therapeutics terminates $25M equity purchase agreement with Lincoln Park Capital

## Summary
- Terminated Purchase Agreement with Lincoln Park Capital Fund effective March 1, 2024.
- Only 12,500 shares were sold under the agreement, generating ~$33,000 in proceeds.
- Company projects financial runway through Q4 2025; no immediate capital need.
- No early termination penalties; 1.8M commitment shares previously issued to LPC.

## SEC filing metadata
- accession: 0001104659-24-029638
- form_type: 8-K
- ticker: MRKR
- cik: 0001094038
- company_name: Marker Therapeutics, Inc.
- filed_at: 2024-03-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1094038/000110465924029638/0001104659-24-029638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1094038/000110465924029638/tm247674d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-029638
- JSON: https://secwatch.observer/filing/0001104659-24-029638.json
- Plain text: https://secwatch.observer/filing/0001104659-24-029638.txt

## Key facts
- Material Agreements
  Marker Therapeutics, Inc. terminated Purchase Agreement with Lincoln Park Capital Fund, LLC (effective 2024-03-01).
  - Action: termination
  - Agreement: equity purchase
  - Counterparty: Lincoln Park Capital Fund, LLC
  - Effective: 2024-03-01
  source text: On February 29, 2024, Marker Therapeutics, Inc. (the “Company”) delivered notice to Lincoln Park Capital Fund, LLC, an Illinois limited liability company (“LPC”), terminating the Purchase Agreement, dated December 12, 2022 (the “Purchase Agreement”), with LPC effective March 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465924029638/0001104659-24-029638-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.